Dr Jeffrey Wade Oseid, MD | |
501 E Nicollet Blvd, Ste 200, Burnsville, MN 55337-6732 | |
(952) 831-1944 | |
(952) 278-6947 |
Full Name | Dr Jeffrey Wade Oseid |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 501 E Nicollet Blvd, Burnsville, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417060401 | NPI | - | NPPES |
40897OS | Other | MN | BC/BS |
1219472 | Other | MN | MEDICA |
FP9020802019 | Other | MN | PREFERRED ONE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 33615 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Wade Oseid, MD 3955 Parklawn Ave, Ste 120, Edina, MN 55435-5655 Ph: (952) 831-1944 | Dr Jeffrey Wade Oseid, MD 501 E Nicollet Blvd, Ste 200, Burnsville, MN 55337-6732 Ph: (952) 831-1944 |
News Archive
In a breakthrough discovery at the Children's Medical Center Research Institute at UT Southwestern (CRI), a research team led by Ralph DeBerardinis, M.D., Ph.D., has taken a significant step in cracking the code of an atypical metabolic pathway that allows certain cancerous tumors to thrive, providing a possible roadmap for defeating such cancers.
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
Major depression (MD) and alcohol dependence (AD) co-occur in individuals and within families at higher rates than expected by chance. This study looked at how mood-related drinking motives may explain the overlapping familial risk for MD and AD. Findings suggest that individuals with strong mood-related drinking motives, especially those based on negative feelings, may be vulnerable to developing both MD and AD.
Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.
› Verified 4 days ago
Dr. Sheila J Jenkins, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8700 | |
Kristine A Foslien, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 303 Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-8770 | |
Dr. Lisa Wilkinson Oie, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 501 E Nicollet Blvd, Ste 200, Burnsville, MN 55337 Phone: 952-831-1944 Fax: 952-278-6947 | |
Brielle Joy Swanstrom, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8700 Fax: 952-993-8516 | |
Dr. Timothy John Anderson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 501 E Nicollet Blvd, Suite 200, Burnsville, MN 55337 Phone: 952-898-5900 Fax: 952-898-5914 | |
Mrs. Gillian Hackedorn Luscri, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8682 | |
Dr. Jens Christian Morkeberg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 501 E Nicollet Blvd, Ste 200, Burnsville, MN 55337 Phone: 952-831-1944 Fax: 952-278-6947 |